Small caps may have climbed to all-time highs, but investors shouldn’t expect a repeat performance, according to Trivector Research.
This insurance stock is breaking out, but remains cheap. How to get long with options
Tony Zhang breaks down a vertical call spread on this health insurance stock.
Get in on the ground floor: An emerging giant in commodities and forex that’s off Wall Street’s radar
Investor Jeff Hirsch profiles an under-the-radar financial powerhouse delivering consistent growth across commodities, FX, and clearing.
Buy this defense giant as its long-term prospects improve, days Deutsche Bank
The bank upgraded the aerospace and defense stock to buy from hold.
JPMorgan upgrades biopharma stock to overweight on strong drug pipeline
JPMorgan foresees shares of Ionis Pharmaceuticals rising another 16% from their Tuesday close after a 170% runup in six months.
How small and big investors are picking AI winners
Frank Holland breaks down what traders are watching ahead of the new session.
Stay away from FedEx as competition heats up and macro headwinds mount, says JPMorgan
JPMorgan is moving to the sidelines when it comes to FedEx.
Guggenheim says this little-known cancer stock can more than double from here
Guggenheim applauded CC Oncology’s immunotherapy development and “potentially attractive catalyst path.”
Morgan Stanley highlights stocks that could see big earnings surprises this quarter
Morgan Stanley highlighted companies such as Roblox and Reddit that could surprise investors to the upside as third quarter earnings are reported.
A bubble may be forming, but there are still good investment opportunities in this market, says Josh Brown
Some AI stocks are vastly overvalued, suggesting there’s a bubble, but that shouldn’t deter pouring new money into good projects, Josh Brown told CNBC.